Multidisciplinary care program for lifestyle changes in prediabetes

Impact of a Multidisciplinary Care Program for Lifestyle Change for Metabolic Control and Quality of Life in Prediabetes: Prediabetes Care Program of Mexico City

NA · Clinica Especializada en el Manejo de la Diabetes en la Ciudad de Mexico · NCT06468553

This study is testing a team-based program to help people with prediabetes make lifestyle changes, like eating better and exercising more, to see if it can prevent them from developing type 2 diabetes.

Quick facts

PhaseNA
Study typeInterventional
Enrollment80 (estimated)
Ages18 Years to 70 Years
SexAll
SponsorClinica Especializada en el Manejo de la Diabetes en la Ciudad de Mexico (network)
Locations1 site (Mexico City, Iztapalapa)
Trial IDNCT06468553 on ClinicalTrials.gov

What this trial studies

This program focuses on implementing a multidisciplinary approach to promote lifestyle changes in individuals diagnosed with prediabetes. It aims to improve metabolic control and quality of life through dietary modifications and increased physical activity, ultimately leading to weight loss. The initiative addresses the specific needs of low- and middle-income populations, where access to such programs is often limited. By utilizing a structured care program, it seeks to prevent the progression to type 2 diabetes and reduce associated health risks.

Who should consider this trial

Good fit: Ideal candidates for this program are individuals diagnosed with prediabetes who are willing to commit to lifestyle changes.

Not a fit: Patients with existing diabetes or advanced diseases that limit their life expectancy are unlikely to benefit from this program.

Why it matters

Potential benefit: If successful, this program could significantly reduce the risk of developing type 2 diabetes and improve overall health outcomes for patients with prediabetes.

How similar studies have performed: While similar lifestyle intervention programs have shown success in higher-income countries, this approach is novel in the context of low- and middle-income countries.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Having diagnosis of prediabetes
* Acceptance for participation in the program by signing informed consent sheet

Exclusion Criteria:

* Any type of diabetes
* Advanced diseases such as ischemic heart disease, heart failure, KDOQI renal failure ≥1, cerebral vascular disease with functional sequelae or those who have comorbidities that limit their life expectancy such as malignant tumors in advanced stages
* Dependence of illicit drugs
* Conditions that require short-term surgical treatment.
* Pregnancy
* Advanced cognitive deficit or serious psychiatric disorders that hinder treatment adherence
* Use of medications whose use is associated with alterations in blood glucose levels or weight gain or loss, e.g. e.g. metformin, Glucagon-like peptide-1 receptor agonists, orlistat or corticosteroids
* Actively taking any supplements dietary or under naturopathic, homeopathic or alternative therapies
* Have any type of bariatric surgery procedure or weight loss device
* Current participation in another lifestyle, behavior change, or weight loss or gain program or research study

Where this trial is running

Mexico City, Iztapalapa

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: PreDiabetes, glycemic control, weight loss, Healthy Lifestyle, Prediabetic State, quality of life, Glucose Metabolism Disorders, Behavior and Behavior Mechanisms

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.